Sarcopenia/Frailty - Eos SENOLYTIX

Sarcopenia/Frailty

Greater lean-body-mass decline with tirzepatide than semaglutide in routine care revealed by body-composition digital phenotyping

April 13, 2026

Unintended risks of sarcopenic obesity during weight-loss interventions in older people

February 5, 2026

Muscle-preserving therapies in the era of pharmacological weight loss

January 2, 2026

Inhibition Of IL-11 Signalling Extends Mammalian Healthspan and Lifespan

June 11, 2024

Senescent Cell Transplantation into the Skin Induces Age-Related Peripheral Dysfunction and Cognitive Decline

May 22, 2024

Prophylactic and Long-Lasting Efficacy of Senolytic CAR T Cells Against Age-Related Metabolic Dysfunction

January 24, 2024

Whole‐Body Senescent Cell Clearance Alleviates Age‐Related Brain Inflammation and Cognitive Impairment In Mice

October 30, 2020

Skeletal Muscle Mass as a Mortality Predictor among Nonagenarians and Centenarians: A Prospective Cohort Study

February 20, 2019

Targeting Senescent Cells Alleviates Obesity‐Induced Metabolic Dysfunction

January 25, 2019

Naturally Occurring p16ink4a-Positive Cells Shorten Healthy Lifespan

February 11, 2016

Mitochondria to Motion- Optimizing Oxidative Phosphorylation to Improve Exercise Performance

January 1, 2016

Clearance of p16ink4a-Positive Senescent Cells Delays Ageing-Associated Disorders

November 10, 2011

Reduced Mitochondrial Coupling in vivo Alters Cellular Energetics in Aged Mouse Skeletal Muscle

October 27, 2005

Ageing Oxidative Stress and Mitochondrial Uncoupling

August 24, 2004

Oxidative Capacity and Ageing in Human Muscle

March 24, 2000

Categories

Archives

© 2026 Eos SENOLYTIX.